nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—AGTR1—GPCR downstream signaling—AVP—autistic disorder	0.000836	0.000836	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—OXTR—autistic disorder	0.000827	0.000827	CbGpPWpGaD
Valsartan—ALB—Metabolism—BTD—autistic disorder	0.000824	0.000824	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—GABRB2—autistic disorder	0.000819	0.000819	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—GABRA2—autistic disorder	0.000819	0.000819	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—SCT—autistic disorder	0.000819	0.000819	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—autistic disorder	0.000813	0.000813	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—GSTM1—autistic disorder	0.000809	0.000809	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—PLA2G4A—autistic disorder	0.000808	0.000808	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—ADRB2—autistic disorder	0.000808	0.000808	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—IL6—autistic disorder	0.000802	0.000802	CbGpPWpGaD
Valsartan—CYP2C9—Metapathway biotransformation—GSTM1—autistic disorder	0.000797	0.000797	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—TPH2—autistic disorder	0.000794	0.000794	CbGpPWpGaD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—autistic disorder	0.000792	0.000792	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—RORA—autistic disorder	0.000786	0.000786	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—DPYD—autistic disorder	0.000781	0.000781	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—GABBR1—autistic disorder	0.000781	0.000781	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ADM—autistic disorder	0.000781	0.000781	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	0.000781	0.000781	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—EIF4E—autistic disorder	0.000767	0.000767	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—ITGB3—autistic disorder	0.000766	0.000766	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—NPAS2—autistic disorder	0.000765	0.000765	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PDE4B—autistic disorder	0.000761	0.000761	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—AVP—autistic disorder	0.000759	0.000759	CbGpPWpGaD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—autistic disorder	0.000758	0.000758	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ADSL—autistic disorder	0.000757	0.000757	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ACADSB—autistic disorder	0.000756	0.000756	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—INPP1—autistic disorder	0.000756	0.000756	CbGpPWpGaD
Valsartan—ALB—SLC-mediated transmembrane transport—AVP—autistic disorder	0.000755	0.000755	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—XDH—autistic disorder	0.000743	0.000743	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—OPRM1—autistic disorder	0.000737	0.000737	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	0.000734	0.000734	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—SLC1A3—autistic disorder	0.00073	0.00073	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—AQP4—autistic disorder	0.00073	0.00073	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—STX1A—autistic disorder	0.000729	0.000729	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—NPAS2—autistic disorder	0.000729	0.000729	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CACNA1C—autistic disorder	0.000726	0.000726	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—PLA2G4A—autistic disorder	0.000714	0.000714	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—TCN2—autistic disorder	0.000704	0.000704	CbGpPWpGaD
Valsartan—ALB—Metabolism—TDO2—autistic disorder	0.0007	0.0007	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—autistic disorder	0.000698	0.000698	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—HTR2A—autistic disorder	0.000696	0.000696	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—BTD—autistic disorder	0.000674	0.000674	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—GZMB—autistic disorder	0.000674	0.000674	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ADA—autistic disorder	0.000672	0.000672	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—AVP—autistic disorder	0.000671	0.000671	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	0.000664	0.000664	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—DHFR—autistic disorder	0.000661	0.000661	CbGpPWpGaD
Valsartan—ALB—Metabolism—DHCR7—autistic disorder	0.000658	0.000658	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—OXT—autistic disorder	0.000654	0.000654	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HTR1B—autistic disorder	0.000654	0.000654	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—IL6—autistic disorder	0.000653	0.000653	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—CP—autistic disorder	0.000651	0.000651	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—RORA—autistic disorder	0.000643	0.000643	CbGpPWpGaD
Valsartan—ALB—Hemostasis—TF—autistic disorder	0.000639	0.000639	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	0.000636	0.000636	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—HTR2A—autistic disorder	0.000632	0.000632	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—PRKCB—autistic disorder	0.000627	0.000627	CbGpPWpGaD
Valsartan—ALB—Metabolism—EXT1—autistic disorder	0.000624	0.000624	CbGpPWpGaD
Valsartan—ALB—Metabolism—SLC6A8—autistic disorder	0.000624	0.000624	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—RORA—autistic disorder	0.000612	0.000612	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—PRKCB—autistic disorder	0.00061	0.00061	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TSC1—autistic disorder	0.000608	0.000608	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—DRD1—autistic disorder	0.000608	0.000608	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—PIK3CG—autistic disorder	0.0006	0.0006	CbGpPWpGaD
Valsartan—ALB—Metabolism—DAO—autistic disorder	0.000595	0.000595	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—EGF—autistic disorder	0.000593	0.000593	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NTRK2—autistic disorder	0.000592	0.000592	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—DRD3—autistic disorder	0.000589	0.000589	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—PIK3CG—autistic disorder	0.000584	0.000584	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL5—autistic disorder	0.000577	0.000577	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—MAOB—autistic disorder	0.000574	0.000574	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—TDO2—autistic disorder	0.000573	0.000573	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—POMC—autistic disorder	0.000571	0.000571	CbGpPWpGaD
Valsartan—ALB—Metabolism—UPB1—autistic disorder	0.000571	0.000571	CbGpPWpGaD
Valsartan—ALB—Hemostasis—IL5—autistic disorder	0.00057	0.00057	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CALCA—autistic disorder	0.00057	0.00057	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	0.000557	0.000557	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—POMC—autistic disorder	0.000556	0.000556	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—PRKCB—autistic disorder	0.000554	0.000554	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—TF—autistic disorder	0.000553	0.000553	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—IGF1—autistic disorder	0.00055	0.00055	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—autistic disorder	0.000546	0.000546	CbGpPWpGaD
Valsartan—ALB—Hemostasis—ITGA4—autistic disorder	0.000544	0.000544	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—DHCR7—autistic disorder	0.000539	0.000539	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—TPH2—autistic disorder	0.000534	0.000534	CbGpPWpGaD
Valsartan—ALB—Metabolism—GSTM5—autistic disorder	0.000531	0.000531	CbGpPWpGaD
Valsartan—ALB—Metabolism—ASMT—autistic disorder	0.000531	0.000531	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—PIK3CG—autistic disorder	0.00053	0.00053	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—DPYD—autistic disorder	0.000525	0.000525	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—SERPINE1—autistic disorder	0.000522	0.000522	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—IL6—autistic disorder	0.000519	0.000519	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CYP19A1—autistic disorder	0.000518	0.000518	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—EXT1—autistic disorder	0.000511	0.000511	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—SLC6A8—autistic disorder	0.000511	0.000511	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—POMC—autistic disorder	0.000505	0.000505	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PRL—autistic disorder	0.000503	0.000503	CbGpPWpGaD
Valsartan—ALB—Metabolism—SLC25A12—autistic disorder	0.000499	0.000499	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PLAUR—autistic disorder	0.000496	0.000496	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	0.000493	0.000493	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CACNA1C—autistic disorder	0.000488	0.000488	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—DAO—autistic disorder	0.000487	0.000487	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	0.000486	0.000486	CbGpPWpGaD
Valsartan—ALB—Metabolism—SLC19A1—autistic disorder	0.000485	0.000485	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—COMT—autistic disorder	0.000481	0.000481	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GSTP1—autistic disorder	0.000479	0.000479	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—MAOA—autistic disorder	0.000478	0.000478	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ADRB2—autistic disorder	0.000477	0.000477	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—autistic disorder	0.000469	0.000469	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—UPB1—autistic disorder	0.000467	0.000467	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CAT—autistic disorder	0.000466	0.000466	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—AVP—autistic disorder	0.000448	0.000448	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IGF2—autistic disorder	0.000447	0.000447	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	0.000446	0.000446	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—DHFR—autistic disorder	0.000444	0.000444	CbGpPWpGaD
Valsartan—ALB—Hemostasis—IGF2—autistic disorder	0.000441	0.000441	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PLA2G4A—autistic disorder	0.00044	0.00044	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GSTM1—autistic disorder	0.00044	0.00044	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ASMT—autistic disorder	0.000434	0.000434	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GSTM5—autistic disorder	0.000434	0.000434	CbGpPWpGaD
Valsartan—ALB—Metabolism—ADSL—autistic disorder	0.000433	0.000433	CbGpPWpGaD
Valsartan—ALB—Metabolism—XDH—autistic disorder	0.000424	0.000424	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—IL2—autistic disorder	0.000422	0.000422	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PLA2G4A—autistic disorder	0.000422	0.000422	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GPX1—autistic disorder	0.000421	0.000421	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PLA2G4A—autistic disorder	0.000417	0.000417	CbGpPWpGaD
Valsartan—ALB—Metabolism—STX1A—autistic disorder	0.000416	0.000416	CbGpPWpGaD
Valsartan—ALB—Metabolism—NPAS2—autistic disorder	0.000416	0.000416	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—IL2—autistic disorder	0.000411	0.000411	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MEF2C—autistic disorder	0.00041	0.00041	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—SLC25A12—autistic disorder	0.000408	0.000408	CbGpPWpGaD
Valsartan—ALB—Metabolism—TCN2—autistic disorder	0.000402	0.000402	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ITGB3—autistic disorder	0.0004	0.0004	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—SLC19A1—autistic disorder	0.000397	0.000397	CbGpPWpGaD
Valsartan—ALB—Hemostasis—ITGB3—autistic disorder	0.000395	0.000395	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—MTHFR—autistic disorder	0.000389	0.000389	CbGpPWpGaD
Valsartan—ALB—Metabolism—ADA—autistic disorder	0.000384	0.000384	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—AVP—autistic disorder	0.000384	0.000384	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	0.000379	0.000379	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	0.000374	0.000374	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HTR2A—autistic disorder	0.000373	0.000373	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—IL2—autistic disorder	0.000373	0.000373	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	0.000365	0.000365	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	0.000363	0.000363	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—APOE—autistic disorder	0.000362	0.000362	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TSC2—autistic disorder	0.000355	0.000355	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ADSL—autistic disorder	0.000354	0.000354	CbGpPWpGaD
Valsartan—ALB—Metabolism—RORA—autistic disorder	0.00035	0.00035	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CYP19A1—autistic disorder	0.000348	0.000348	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—XDH—autistic disorder	0.000347	0.000347	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—APOE—autistic disorder	0.000347	0.000347	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—LEP—autistic disorder	0.000347	0.000347	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—NPAS2—autistic disorder	0.000341	0.000341	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—STX1A—autistic disorder	0.000341	0.000341	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—TCN2—autistic disorder	0.000329	0.000329	CbGpPWpGaD
Valsartan—ALB—Metabolism—MAOB—autistic disorder	0.000328	0.000328	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PRKCB—autistic disorder	0.000327	0.000327	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PIK3CG—autistic disorder	0.000327	0.000327	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	0.000326	0.000326	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PRKCB—autistic disorder	0.000323	0.000323	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—COMT—autistic disorder	0.000323	0.000323	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—MAPK1—autistic disorder	0.000323	0.000323	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GSTP1—autistic disorder	0.000322	0.000322	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—MAOA—autistic disorder	0.000321	0.000321	CbGpPWpGaD
Valsartan—ALB—Hemostasis—NOS2—autistic disorder	0.000319	0.000319	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ADA—autistic disorder	0.000314	0.000314	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PIK3CG—autistic disorder	0.000313	0.000313	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—APC—autistic disorder	0.000313	0.000313	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CAT—autistic disorder	0.000313	0.000313	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—APOE—autistic disorder	0.000312	0.000312	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—POMC—autistic disorder	0.000311	0.000311	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	0.00031	0.00031	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—EGF—autistic disorder	0.00031	0.00031	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PIK3CG—autistic disorder	0.000309	0.000309	CbGpPWpGaD
Valsartan—ALB—Hemostasis—EGF—autistic disorder	0.000306	0.000306	CbGpPWpGaD
Valsartan—ALB—Metabolism—TPH2—autistic disorder	0.000305	0.000305	CbGpPWpGaD
Valsartan—ALB—Metabolism—DPYD—autistic disorder	0.0003	0.0003	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—POMC—autistic disorder	0.000298	0.000298	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	0.000297	0.000297	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GSTM1—autistic disorder	0.000296	0.000296	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PLA2G4A—autistic disorder	0.000296	0.000296	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IGF1—autistic disorder	0.000287	0.000287	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—RORA—autistic disorder	0.000286	0.000286	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—MAPK1—autistic disorder	0.000285	0.000285	CbGpPWpGaD
Valsartan—ALB—Hemostasis—IGF1—autistic disorder	0.000283	0.000283	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GPX1—autistic disorder	0.000283	0.000283	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	0.000282	0.000282	CbGpPWpGaD
Valsartan—ALB—Metabolism—CACNA1C—autistic disorder	0.000279	0.000279	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—SERPINE1—autistic disorder	0.000272	0.000272	CbGpPWpGaD
Valsartan—ALB—Hemostasis—SERPINE1—autistic disorder	0.000269	0.000269	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—MAOB—autistic disorder	0.000268	0.000268	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—POMC—autistic disorder	0.000268	0.000268	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—MTHFR—autistic disorder	0.000261	0.000261	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—autistic disorder	0.000255	0.000255	CbGpPWpGaD
Valsartan—ALB—Metabolism—DHFR—autistic disorder	0.000254	0.000254	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—TPH2—autistic disorder	0.00025	0.00025	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PTGS2—autistic disorder	0.000248	0.000248	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—DPYD—autistic disorder	0.000245	0.000245	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—APOE—autistic disorder	0.000243	0.000243	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	0.000231	0.000231	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—HRAS—autistic disorder	0.000229	0.000229	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CACNA1C—autistic disorder	0.000228	0.000228	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL2—autistic disorder	0.00022	0.00022	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PIK3CG—autistic disorder	0.00022	0.00022	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—autistic disorder	0.000219	0.000219	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—IL6—autistic disorder	0.000219	0.000219	CbGpPWpGaD
Valsartan—ALB—Hemostasis—IL2—autistic disorder	0.000218	0.000218	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PTEN—autistic disorder	0.000216	0.000216	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	0.000214	0.000214	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—POMC—autistic disorder	0.000209	0.000209	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—DHFR—autistic disorder	0.000208	0.000208	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PTEN—autistic disorder	0.000207	0.000207	CbGpPWpGaD
Valsartan—ALB—Metabolism—CYP19A1—autistic disorder	0.000199	0.000199	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	0.000186	0.000186	CbGpPWpGaD
Valsartan—ALB—Metabolism—COMT—autistic disorder	0.000185	0.000185	CbGpPWpGaD
Valsartan—ALB—Metabolism—GSTP1—autistic disorder	0.000184	0.000184	CbGpPWpGaD
Valsartan—ALB—Metabolism—MAOA—autistic disorder	0.000183	0.000183	CbGpPWpGaD
Valsartan—ALB—Metabolism—CAT—autistic disorder	0.000179	0.000179	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	0.000175	0.000175	CbGpPWpGaD
Valsartan—ALB—Metabolism—PLA2G4A—autistic disorder	0.000169	0.000169	CbGpPWpGaD
Valsartan—ALB—Metabolism—GSTM1—autistic disorder	0.000169	0.000169	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MAPK1—autistic disorder	0.000169	0.000169	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PTGS2—autistic disorder	0.000167	0.000167	CbGpPWpGaD
Valsartan—ALB—Hemostasis—MAPK1—autistic disorder	0.000167	0.000167	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CYP19A1—autistic disorder	0.000163	0.000163	CbGpPWpGaD
Valsartan—ALB—Metabolism—GPX1—autistic disorder	0.000162	0.000162	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	0.000153	0.000153	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—COMT—autistic disorder	0.000151	0.000151	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GSTP1—autistic disorder	0.00015	0.00015	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—MAOA—autistic disorder	0.00015	0.00015	CbGpPWpGaD
Valsartan—ALB—Metabolism—MTHFR—autistic disorder	0.000149	0.000149	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CAT—autistic disorder	0.000146	0.000146	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PTEN—autistic disorder	0.000145	0.000145	CbGpPWpGaD
Valsartan—ALB—Metabolism—APOE—autistic disorder	0.000139	0.000139	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GSTM1—autistic disorder	0.000138	0.000138	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PLA2G4A—autistic disorder	0.000138	0.000138	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HRAS—autistic disorder	0.000135	0.000135	CbGpPWpGaD
Valsartan—ALB—Hemostasis—HRAS—autistic disorder	0.000134	0.000134	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GPX1—autistic disorder	0.000132	0.000132	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL6—autistic disorder	0.00013	0.00013	CbGpPWpGaD
Valsartan—ALB—Metabolism—PIK3CG—autistic disorder	0.000125	0.000125	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—MTHFR—autistic disorder	0.000122	0.000122	CbGpPWpGaD
Valsartan—ALB—Metabolism—POMC—autistic disorder	0.000119	0.000119	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—APOE—autistic disorder	0.000114	0.000114	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PIK3CG—autistic disorder	0.000103	0.000103	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—POMC—autistic disorder	9.77e-05	9.77e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—PTGS2—autistic disorder	9.52e-05	9.52e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—PTEN—autistic disorder	8.31e-05	8.31e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PTGS2—autistic disorder	7.79e-05	7.79e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PTEN—autistic disorder	6.8e-05	6.8e-05	CbGpPWpGaD
